Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in nonhuman primates
Open Access
- 5 August 2025
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 156 (5) , 1328-1340
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Briquilimab, An Anti-CD117 Antibody, Prevents Cockroach Allergen Induced Allergic Asthma In Mice Expressing Chimeric Human And Mouse CD117Journal of Allergy and Clinical Immunology, 2024
- A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitorsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcus aureusImmunity, 2020
- Mast Cells Are Crucial for Induction of Group 2 Innate Lymphoid Cells and Clearance of Helminth InfectionsImmunity, 2017
- The Role of Mast Cells in Bacterial InfectionThe American Journal of Pathology, 2016
- Measuring Mast Cell Mediator ReleaseCurrent Protocols in Immunology, 2010
- Antagonists of CD117 (cKit) signaling inhibit mast cell accumulation in healing skin woundsCytometry Part A, 2008
- Structural Basis for Activation of the Receptor Tyrosine Kinase KIT by Stem Cell FactorCell, 2007
- Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptorsBiochemical and Biophysical Research Communications, 2006
- The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transductionCell, 1995